VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,165 | -66.9% | 39,390 | -49.4% | 0.00% | -100.0% |
| Q2 2023 | $513,506 | -53.3% | 77,922 | -51.9% | 0.00% | -50.0% |
| Q1 2023 | $1,099,994 | +108.4% | 162,002 | +126.8% | 0.00% | +100.0% |
| Q4 2022 | $527,860 | -99.9% | 71,429 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $829,505,000 | +272.2% | 83,958 | +310.6% | 0.00% | – |
| Q2 2022 | $222,861,000 | -18.9% | 20,446 | -15.9% | 0.00% | – |
| Q1 2022 | $274,923,000 | -51.3% | 24,308 | -32.5% | 0.00% | -100.0% |
| Q4 2021 | $564,981,000 | -49.8% | 36,009 | -45.2% | 0.00% | -50.0% |
| Q3 2021 | $1,126,321,000 | +80.3% | 65,713 | +126.2% | 0.00% | +100.0% |
| Q2 2021 | $624,866,000 | +38.2% | 29,050 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $452,207,000 | +17.8% | 30,107 | +3.0% | 0.00% | 0.0% |
| Q4 2020 | $383,964,000 | +189.5% | 29,221 | +112.8% | 0.00% | – |
| Q3 2020 | $132,641,000 | -80.3% | 13,731 | -76.7% | 0.00% | -100.0% |
| Q2 2020 | $674,079,000 | +114.8% | 58,923 | +94.5% | 0.00% | 0.0% |
| Q1 2020 | $313,887,000 | +61.7% | 30,298 | +156.2% | 0.00% | – |
| Q4 2019 | $194,081,000 | +78.4% | 11,827 | +44.4% | 0.00% | – |
| Q3 2019 | $108,790,000 | +34.7% | 8,192 | +42.9% | 0.00% | – |
| Q2 2019 | $80,792,000 | -58.9% | 5,734 | -46.3% | 0.00% | – |
| Q1 2019 | $196,622,000 | +44184.2% | 10,686 | +62758.8% | 0.00% | – |
| Q4 2018 | $444,000 | -98.9% | 17 | -99.0% | 0.00% | – |
| Q3 2018 | $39,084,000 | +20.5% | 1,703 | 0.0% | 0.00% | – |
| Q2 2018 | $32,442,000 | -79.4% | 1,703 | -81.8% | 0.00% | – |
| Q1 2018 | $157,413,000 | +11.7% | 9,342 | +0.8% | 0.00% | – |
| Q4 2017 | $140,889,000 | +74.8% | 9,269 | +105.8% | 0.00% | – |
| Q3 2017 | $80,622,000 | +3.3% | 4,504 | -5.9% | 0.00% | – |
| Q2 2017 | $78,044,000 | +2593.0% | 4,788 | +2213.0% | 0.00% | – |
| Q1 2017 | $2,898,000 | -91.1% | 207 | -89.9% | 0.00% | – |
| Q4 2016 | $32,745,000 | -22.4% | 2,053 | -19.0% | 0.00% | – |
| Q3 2016 | $42,199,000 | -91.3% | 2,536 | -94.2% | 0.00% | -100.0% |
| Q2 2016 | $486,888,000 | +38.3% | 43,511 | +3.4% | 0.00% | +100.0% |
| Q1 2016 | $351,956,000 | -59.7% | 42,100 | -55.1% | 0.00% | -50.0% |
| Q4 2015 | $872,458,000 | +754.4% | 93,712 | +935.1% | 0.00% | – |
| Q3 2015 | $102,118,000 | +131.4% | 9,053 | +160.4% | 0.00% | – |
| Q2 2015 | $44,123,000 | +410.7% | 3,477 | +274.3% | 0.00% | – |
| Q1 2015 | $8,640,000 | -59.0% | 929 | -54.3% | 0.00% | – |
| Q3 2014 | $21,092,000 | +295.3% | 2,032 | +372.6% | 0.00% | – |
| Q4 2013 | $5,336,000 | -94.5% | 430 | -96.4% | 0.00% | – |
| Q2 2013 | $97,590,000 | – | 12,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |